Guillaume Peyraga

Guillaume Peyraga

UNVERIFIED PROFILE

Are you Guillaume Peyraga?   Register this Author

Register author
Guillaume Peyraga

Guillaume Peyraga

Publications by authors named "Guillaume Peyraga"

Are you Guillaume Peyraga?   Register this Author

8Publications

131Reads

49Profile Views

Cost-Effectiveness of Web-Based Patient-Reported Outcome Surveillance in Patients With Lung Cancer.

J Thorac Oncol 2019 06 15;14(6):1012-1020. Epub 2019 Feb 15.

Department of Radiation Oncology, Jean Bernard Center, Inter-Regional Institute of Oncology, Le Mans, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.02.005DOI Listing
June 2019

Molecular PET imaging in adaptive radiotherapy: brain.

Q J Nucl Med Mol Imaging 2018 Dec;62(4):337-348

Department of Radiation Therapy, Claudius Regaud Institute, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France -

View Article

Download full-text PDF

Source
http://dx.doi.org/10.23736/S1824-4785.18.03116-3DOI Listing
December 2018

Cutaneous and Gastrointestinal Leukocytoclastic Vasculitis Induced by Palbociclib in a Metastatic Breast Cancer Patient: A Case Report.

Clin Breast Cancer 2018 10 16;18(5):e755-e758. Epub 2018 Aug 16.

Medical Oncology Department, Institut de Cancérologie de l'Ouest, Centre Paul Papin, Angers, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15268209183031
Publisher Site
http://dx.doi.org/10.1016/j.clbc.2018.07.006DOI Listing
October 2018

Digestive toxicities after palliative three-dimensional conformal radiation therapy (3D-CRT) for cervico-thoracic spinal metastases.

Support Care Cancer 2018 Jun 23;26(6):1897-1903. Epub 2017 Dec 23.

Department of Radiation Therapy, Jean Bernard Center, 9 Rue Beauverger, 72000, Le Mans, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-017-4001-4DOI Listing
June 2018

Exclusive concurrent radiochemotherapy for advanced head and neck cancers with 'fractionated' 5-fluorouracil and cisplatin.

Anticancer Drugs 2017 02;28(2):213-221

Departments of aOncopharmacology-Pharmacogenetics bRadiotherapy cBiostatistics, Integrated Center of Oncology (ICO) Paul Papin dDepartment of Head and Neck Surgery, University Hospital Center, Angers eDepartment of Head and Neck Surgery, University Hospital Center, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000440DOI Listing
February 2017

Feasibility and safety of dose-dense modified docetaxel-cisplatin or carboplatin and 5-fluorouracil regimen (mTPF) in locally advanced or metastatic head and neck cancers: a retrospective monocentric study.

Int J Clin Oncol 2015 Dec 1;20(6):1086-92. Epub 2015 May 1.

Department of Oncopharmacology-Pharmacogenetics, Integrated Center of Oncology (ICO) Paul Papin, 2 rue Moll, 49033, Angers Cedex 9, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10147-015-0836-1
Publisher Site
http://dx.doi.org/10.1007/s10147-015-0836-1DOI Listing
December 2015